logo
#

Latest news with #CleanScience&Technology

Clean Science shares tank 7% post Q1 results; should you buy, sell or hold?
Clean Science shares tank 7% post Q1 results; should you buy, sell or hold?

Business Standard

time18-07-2025

  • Business
  • Business Standard

Clean Science shares tank 7% post Q1 results; should you buy, sell or hold?

Clean Science share price today: Shares of chemical manufacturer Clean Science & Technology crashed over 7 per cent to hit an intra-day low of ₹1,332.4 on the NSE after it reported its June 2025 quarter (Q1FY26) results. At 11:45 AM, the stock was trading 7.4 per cent lower at ₹1,338 compared to the previous day's close of ₹1,445.2 on the NSE. In comparison, the benchmark NSE Nifty 50 index was trading at 24,953.90 levels, down by 157.55 points or 0.63 per cent. The company's total market capitalisation stood at ₹14,271.69 crore. The stock has plunged over 21 per cent from its 52-week high of ₹1,690 touched on August 1, 2024. Clean Science & Technology Q1FY26 result update Clean Science's consolidated revenue from operations for the June 2025 quarter came in at ₹242.86 crore, up 8.4 per cent year-on-year (Y-o-Y) from ₹224 crore in the year-ago period. The company reported a 6.2 per cent Y-o-Y increase in profit after tax (PAT) to ₹70 crore against ₹65.9 crore in the June 2024 quarter. Its earnings before interest, tax, depreciation and amortisation (Ebitda) stood at ₹100 crore, up 5 per cent Y-o-Y from ₹95 crore in the year-ago period. Ebitda margin slipped to 41.7 per cent from 42.8 per cent. During the earnings call, the management highlighted that the promoters are evaluating the possibility of selling a minority stake to support the family estate planning. Currently, the promoters own a 74.97 per cent stake in the company. Brokerage views on Clean Science & Technology: JM Financial According to analysts at JM Financial, Clean Science's Q1 Ebitda was in line with their estimates. "We expect the subsidiary to start contributing positively from Q3FY26, driven by the ramp-up of value-added HALS grades. Besides HALS, the company's two new performance chemical capacities are on track to be commercialised, with one set to see commercial production in September 2025 and the other in Q4FY26, the brokerage said in a note. The brokerage has maintained a 'Buy' with a revised September 2026 TP of ₹1,780 per share (from ₹1,820 earlier), based on 40x Sep'27E EPS. Motilal Oswal Financial Services (MOFSL) "While the non-established products face demand softness, we expect the established products, which contribute to 83 per cent of standalone sales, to continue to deliver steady growth, coupled with the commissioning of Performance Chemical 1 in Q2FY26 and Performance Chemical 2 by Q4FY26, are expected to be an additional revenue driver," the brokerage said. MOFSL has lowered its estimates for FY26/FY27 cuts by 9 per cent each, owing to higher tax rates and expects a revenue/ Ebitda/ PAT CAGR of 23/23/27 per cent during FY25-27E. The brokerage has maintained a 'Neutral' rating with a target price of ₹1,350. About Clean Science & Technology Incorporated in 2003, Clean Science and Technology is engaged in the manufacturing of performance chemicals, pharma and agrochemicals, and FMCG chemicals. The company is involved in B2B business and its products find applications in various critical end-user industries and everyday product verticals, including precursors for agricultural chemicals, antioxidants for food and infant food formulations, precursors to manufacture APIs for cough syrup, polymers and monomers, the cosmetic industry, perfumes, and many other applications. Clean Science serves both national and international clients, including institutions, distributors, and dealers. It has a presence in 16 states in India and 36 countries worldwide.

Clean Science & Technology consolidated net profit rises 6.26% in the June 2025 quarter
Clean Science & Technology consolidated net profit rises 6.26% in the June 2025 quarter

Business Standard

time17-07-2025

  • Business
  • Business Standard

Clean Science & Technology consolidated net profit rises 6.26% in the June 2025 quarter

Sales rise 8.42% to Rs 242.87 croreNet profit of Clean Science & Technology rose 6.26% to Rs 70.06 crore in the quarter ended June 2025 as against Rs 65.93 crore during the previous quarter ended June 2024. Sales rose 8.42% to Rs 242.87 crore in the quarter ended June 2025 as against Rs 224.01 crore during the previous quarter ended June EndedJun. 2025Jun. 2024% 8 OPM %41.1142.26 -PBDT113.21104.48 8 PBT94.5588.70 7 NP70.0665.93 6 Powered by Capital Market - Live News

JM Financial maintains Buy on Clean Science & Technology, revises target price to Rs 1,650
JM Financial maintains Buy on Clean Science & Technology, revises target price to Rs 1,650

Economic Times

time28-05-2025

  • Business
  • Economic Times

JM Financial maintains Buy on Clean Science & Technology, revises target price to Rs 1,650

Live Events (You can now subscribe to our (You can now subscribe to our ETMarkets WhatsApp channel JM Financial has maintained its Buy call on Clean Science & Technology with a revised target price of Rs 1,650 (earlier Rs 1,670) The current market price of Clean Science & Technology Ltd. is Rs 1425.9. The time period given by the analyst is a year when Clean Science & Technology price can reach the defined target. Clean Science & Technology, incorporated in 2003, is a Small Cap company with a market cap of Rs 15146.27 crore, operating in the Chemicals Science & Technology's key products/revenue Segments include Specialty Chemicals, Export Incentives, Electricity and Scrap for the year ending the quarter ended 31-03-2025, the company has reported a Consolidated Total Income of Rs 276.06 crore, up 12.20 % from last quarter Total Income of Rs 246.03 crore and up 14.27 % from last year same quarter Total Income of Rs 241.59 crore. The company has reported net profit after tax of Rs 74.09 crore in the latest company's top management includes Rathi, Boob, Sikchi, Boob, Kothari, Yadav, Doshi, Dubhashi, Maheshwari. The company has B S R & Co. LLP as its auditors. As on 31-03-2025, the company has a total of 11 crore shares the basis of 4QFY25 results and management commentary, JM Financial has marginally lowered its FY26-27 EPS estimates for Clean Science & Technology by ~1% to factor in higher depreciation. The brokerage expects ~24%/27% EBITDA/EPS CAGR over FY25-28E. In case there is a pick-up in product prices, there could be an upside risk to their estimates while any delay in new product approvals could be a downside risk. JM Financial maintain sBUY with a revised Mar?26target price of Rs 1,650 (based on 40x Mar?27E EPS) as they see decent growth runway for Clean Science for at least the next 4-5 held 74.97 per cent stake in the company as of 31-Mar-2025, while FIIs owned 6.07 per cent, DIIs 5.77 per cent.

JM Financial maintains Buy on Clean Science & Technology, revises target price to Rs 1,650
JM Financial maintains Buy on Clean Science & Technology, revises target price to Rs 1,650

Time of India

time28-05-2025

  • Business
  • Time of India

JM Financial maintains Buy on Clean Science & Technology, revises target price to Rs 1,650

JM Financial maintains a Buy call on Clean Science & Technology, setting a revised target price of Rs 1,650. The brokerage anticipates substantial EBITDA and EPS growth over the next few years, citing the company's strong Q4FY25 performance. While marginally lowering FY26-27 EPS estimates, they foresee a decent growth runway for Clean Science. Tired of too many ads? Remove Ads Tired of too many ads? Remove Ads (Disclaimer: Views and recommendations given in this section are the analysts' own and do not represent those of Please consult your financial adviser before taking any position in the stock/s mentioned.) JM Financial has maintained its Buy call on Clean Science & Technology with a revised target price of Rs 1,650 (earlier Rs 1,670) The current market price of Clean Science & Technology Ltd. is Rs 1425.9. The time period given by the analyst is a year when Clean Science & Technology price can reach the defined target. Clean Science & Technology, incorporated in 2003, is a Small Cap company with a market cap of Rs 15146.27 crore, operating in the Chemicals Science & Technology's key products/revenue Segments include Specialty Chemicals, Export Incentives, Electricity and Scrap for the year ending the quarter ended 31-03-2025, the company has reported a Consolidated Total Income of Rs 276.06 crore, up 12.20 % from last quarter Total Income of Rs 246.03 crore and up 14.27 % from last year same quarter Total Income of Rs 241.59 crore. The company has reported net profit after tax of Rs 74.09 crore in the latest company's top management includes Rathi, Boob, Sikchi, Boob, Kothari, Yadav, Doshi, Dubhashi, Maheshwari. The company has B S R & Co. LLP as its auditors. As on 31-03-2025, the company has a total of 11 crore shares the basis of 4QFY25 results and management commentary, JM Financial has marginally lowered its FY26-27 EPS estimates for Clean Science & Technology by ~1% to factor in higher depreciation. The brokerage expects ~24%/27% EBITDA/EPS CAGR over FY25-28E. In case there is a pick-up in product prices, there could be an upside risk to their estimates while any delay in new product approvals could be a downside risk. JM Financial maintain sBUY with a revised Mar?26target price of Rs 1,650 (based on 40x Mar?27E EPS) as they see decent growth runway for Clean Science for at least the next 4-5 held 74.97 per cent stake in the company as of 31-Mar-2025, while FIIs owned 6.07 per cent, DIIs 5.77 per cent.

Clean Science & Technology consolidated net profit rises 5.44% in the March 2025 quarter
Clean Science & Technology consolidated net profit rises 5.44% in the March 2025 quarter

Business Standard

time22-05-2025

  • Business
  • Business Standard

Clean Science & Technology consolidated net profit rises 5.44% in the March 2025 quarter

Sales rise 15.89% to Rs 263.68 crore Net profit of Clean Science & Technology rose 5.44% to Rs 74.09 crore in the quarter ended March 2025 as against Rs 70.27 crore during the previous quarter ended March 2024. Sales rose 15.89% to Rs 263.68 crore in the quarter ended March 2025 as against Rs 227.53 crore during the previous quarter ended March 2024. For the full year,net profit rose 8.35% to Rs 264.41 crore in the year ended March 2025 as against Rs 244.03 crore during the previous year ended March 2024. Sales rose 22.13% to Rs 966.64 crore in the year ended March 2025 as against Rs 791.49 crore during the previous year ended March 2024. Particulars Quarter Ended Year Ended Mar. 2025 Mar. 2024 % Var. Mar. 2025 Mar. 2024 % Var. Sales 263.68227.53 16 966.64791.49 22 OPM % 39.7441.54 - 40.1041.95 - PBDT 117.03108.00 8 425.79372.43 14 PBT 99.5895.30 4 356.73326.50 9 NP 74.0970.27 5 264.41244.03 8

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store